Stock listing
LX31 Stock Price, News, Filings & Events — Lexicon Pharmaceuticals, Inc.
Selected listing: LX31 · TRADEGATE · EUR · DE
This page tracks Lexicon Pharmaceuticals, Inc.'s LX31:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LX31:TRADEGATE. LX31:TRADEGATE is the stock-level entry point for investors researching Lexicon Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lexicon Pharmaceuticals, Inc. (ticker: LXRX) is a public company based in the United States with a market capitalization of approximately $1.02 billion. The company focuses on developing innovative therapies for various diseases. Lexicon is committed to advancing its research and development efforts to improve patient outcomes.
- Ticker
- LX31:TRADEGATE
- Asset type
- Stock
- Market cap
- $1.02B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TRADEGATE
- Currency
- EUR
Lexicon Pharmaceuticals, Inc. LX31:TRADEGATE stock context
This page tracks Lexicon Pharmaceuticals, Inc.'s LX31:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LX31:TRADEGATE. LX31:TRADEGATE is the stock-level entry point for investors researching Lexicon Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lexicon Pharmaceuticals, Inc. (ticker: LXRX) is a public company based in the United States with a market capitalization of approximately $1.02 billion. The company focuses on developing innovative therapies for various diseases. Lexicon is committed to advancing its research and development efforts to improve patient outcomes.
Latest news from Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Mile...
August 24, 2026
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
August 7, 2026
Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obst...
July 27, 2026
Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia
June 15, 2026
Lexicon Pharmaceuticals, Inc. earnings calls
Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Lexicon Pharmaceuticals, Inc. (LXRX) Q4 2025 Earnings Call
March 5, 2026 · Replay with transcript and chapters
Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for LX31:TRADEGATE.
Lexicon Pharmaceuticals, Inc. company profile
View the public company page for Lexicon Pharmaceuticals, Inc. on 6ix.
Lexicon Pharmaceuticals, Inc. news
Read company news and market updates connected to Lexicon Pharmaceuticals, Inc..
Lexicon Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Lexicon Pharmaceuticals, Inc..